Lumiradx announces pricing of public offering of common shares and concurrent private placement

London , july 21, 2022 /prnewswire/ -- lumiradx limited (nasdaq: lmdx), a next-generation point of care (poc) diagnostics company, today announced the pricing of its underwritten public offering of 43,000,000 common shares at a price to the public of $1.75 per share. all of the common shares are being offered by lumiradx.
LMDX Ratings Summary
LMDX Quant Ranking